LEARN OF FDA's CURRENT THINKING REGARDING AUDITING ISSUES The FDA recently released a new DRAFT Guidance for Industry on July 12, 2013 that is entitled "Circumstances that Constitute Delaying, Denying, Limiting or Refusing a Drug Inspection".  The Draft Guidance for Industry uses examples that illustrate the most common situations that the FDA has encountered and provides very … [Read more...]